Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients

Masami Tanaka, Kosuke Oikawa, Masakatsu Takanashi et al. · 2009

Read Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients by Masami Tanaka, Kosuke Oikawa, Masakatsu Takanashi et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005532.txt.

Description

Masami Tanaka and co-authors reported a blood marker for acute leukaemia in a 2009 PLOS ONE study. MicroRNAs are short RNA strands that tune how genes are used. Their levels go wrong in many cancers, and some act like cancer drivers while others act as brakes.

The team found that one microRNA, miR-92, drops in the blood plasma of patients with acute leukaemia. A blood test for it could help doctors spot the disease and follow its course. Blood-based markers spare patients some painful bone marrow tests. A marker that falls and rises with the disease could also show early whether treatment is working.

Catalog record

CREATORMasami Tanaka, Kosuke Oikawa, Masakatsu Takanashi et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005532

Browse the full library · About the Tower of Babel